Individuals with two HNPCC-associated cancers a including synchronous and metachronous colorectal cancers or associated extracolonic cancers Individuals with colorectal cancer and a first-degree ...

An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its role in guiding targeted treatments. Genetic testing is a laboratory method ...

Colorectal cancer is more common than many people may realize. Lifetime risk of developing colorectal cancer is 1 in 24 in men and 1 in 26 for women. So, think of being in a room with 100 people and ...

GREENSBORO, N.C. (WGHP) — A test in the Triad that can tell if you have an increased chance of breast cancer, ovarian cancer, colon cancer and heart disease, and it’s completely free. “Some people do ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DUPAGE COUNTY, Ill. (WGN) — It’s a quiet day ...

If you're in your 40s, you might think colon cancer is something to worry about decades from now. But alarming new research ...

FDA has announced it has approved the first genetic test that can help some colorectal cancer patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based ...

Early-stage colon cancer patients could benefit in the future from specific genetic tests that forecast their prognosis and help them make the right decision regarding chemotherapy. Two of the ...

Biomarker testing is changing how colorectal cancer is treated, giving patients more personalized and effective care. By ...

A prospective trial of gastrointestinal cancer patients showed the feasibility of preemptive genetic testing for DPYD/UGT1A1 variants associated with increased chemotherapy toxicity. Genotype-guided ...